October is SCA Awareness Month
The Heart Rhythm Society is calling attention to the need for more public education and research, as well as wider access to life-saving SCA treatments during the first-ever congressionally designated Sudden Cardiac Arrest Awareness Month in October. According to a recent national poll conducted by the Society, 4 out of 5 Americans vastly underestimate the severity of Sudden Cardiac Arrest (SCA), which causes more than 250,000 deaths each year. Learn more »
 |
 |  | Traveling for Heart Rhythm 2009?
Non-U.S. residents may need a visa, which can take up to six months to process, to enter the U.S. for Heart Rhythm 2009. And requirements to travel visa-free have changed in 2008 with the implementation of the Electronic System for Travel Authorization (ESTA). Learn more and request a letter of invitation to attend » |
|
 | | Society & FDA Collaborate on Pacemaker and ICD Lead Workshop
Bruce Wilkoff, MD, FHRS, CCDS; William Maisel, MD and Andrew Krahn, MD represented the Society as participants in the U.S. Food and Drug Administration’s Workshop on Best Practices for Pacemaker and ICD Lead Postmarket Surveillance on October 2-3, 2008. Learn more » |
|
 | | Alternate Training Pathway Sunsets This Month
As published in the 2005 Addendum to the Clinical Competency Statement on training pathways for implantation of ICD and CRT devices, the Alternate Training Pathway expires October 2008. Learn more about this decision and training recommendations » |
|
| New Webcast in Professional Education
Advances in Remote Monitoring: Current Status and Future Perspectives is a new webcast featuring expert clinician faculty. The latest innovations and news related to remote monitoring will be highlighted, including: early automatic detection of events and reimbursement and legal issues pertaining to devices. Learn more » |
|
| Society Provides Comments to CMS on Potential NCD for AF Ablation
In response to CMS’s request for comment on the potential National Coverage Decision (NCD) for AF Ablation, the Society submitted supported comments that demonstrate health benefits in patients who received an ablation for AF. Learn more » |
|
| Warfarin Significantly Underused in AF Treatment
New research published in the October edition of the HeartRhythm Journal reveals that warfarin therapy is significantly underused and/or not used at optimal therapeutic levels in U.S. patients being treated for atrial fibrillation. Learn more » |
|
| Summer Self Study Program Sessions
The final session has posted: Drug Therapy for Stabilization of AF: from Foxglove to Turantulas. Society members have free access to all six of the sessions featured in the Summer Self Study Program and are encouraged to take advantage of this important opportunity to earn CME or CE. Learn more and register today » |
|
| Order New SCA 360° Patient and Clinician Resources
The Society’s SCA 360° materials are intended to support clinicians and their patients as they explore the possible risks and treatment options. Order these new materials for your practice to ensure patients and their families receive clear, easy to understand information. Member discounts are available. Learn more about ordering additional copies » |
|
|
More from Heart Rhythm Society:
